BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 27526323)

  • 1. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.
    Guo H; Ahmed M; Zhang F; Yao CQ; Li S; Liang Y; Hua J; Soares F; Sun Y; Langstein J; Li Y; Poon C; Bailey SD; Desai K; Fei T; Li Q; Sendorek DH; Fraser M; Prensner JR; Pugh TJ; Pomerantz M; Bristow RG; Lupien M; Feng FY; Boutros PC; Freedman ML; Walsh MJ; He HH
    Nat Genet; 2016 Oct; 48(10):1142-50. PubMed ID: 27526323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel lncRNA
    Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
    Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
    Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
    Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
    Hua JT; Ahmed M; Guo H; Zhang Y; Chen S; Soares F; Lu J; Zhou S; Wang M; Li H; Larson NB; McDonnell SK; Patel PS; Liang Y; Yao CQ; van der Kwast T; Lupien M; Feng FY; Zoubeidi A; Tsao MS; Thibodeau SN; Boutros PC; He HH
    Cell; 2018 Jul; 174(3):564-575.e18. PubMed ID: 30033362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
    Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
    Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells.
    Zhang Z; Chng KR; Lingadahalli S; Chen Z; Liu MH; Do HH; Cai S; Rinaldi N; Poh HM; Li G; Sung YY; Heng CL; Core LJ; Tan SK; Ruan X; Lis JT; Kellis M; Ruan Y; Sung WK; Cheung E
    Genome Res; 2019 Feb; 29(2):223-235. PubMed ID: 30606742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.
    Yang L; Lin C; Jin C; Yang JC; Tanasa B; Li W; Merkurjev D; Ohgi KA; Meng D; Zhang J; Evans CP; Rosenfeld MG
    Nature; 2013 Aug; 500(7464):598-602. PubMed ID: 23945587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
    Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
    Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
    Jin HJ; Jung S; DebRoy AR; Davuluri RV
    Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
    Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
    BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
    Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
    Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long noncoding RNA connects c-Myc to tumor metabolism.
    Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
    Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
    Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Insight into the Role of lncRNA in Cancer Susceptibility.
    Gao P; Wei GH
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28598379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Long Non-coding RNA Prostate Cancer-Associated Transcript 1 in Prostate Cancer.
    Yang Y; Yang W; Jin L
    J Comput Biol; 2019 Sep; 26(9):975-984. PubMed ID: 31090454
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive functional annotation of 77 prostate cancer risk loci.
    Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
    PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
    Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel long non-coding RNA PCLN16 facilitates androgen receptor signaling in prostate cancer.
    Shi Z; Chen J; Wumaner A; Li M; Liang C; Li M
    Biochem Biophys Res Commun; 2021 Jan; 537():78-84. PubMed ID: 33387886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer.
    Walavalkar K; Saravanan B; Singh AK; Jayani RS; Nair A; Farooq U; Islam Z; Soota D; Mann R; Shivaprasad PV; Freedman ML; Sabarinathan R; Haiman CA; Notani D
    Nat Commun; 2020 Jul; 11(1):3598. PubMed ID: 32680982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.